In summary, the identification of a novel de novo NSD1 likely pathogenic variant in our patient expands both the mutation and phenotype spectrum associated with Sotos Syndrome, thereby providing valuable insights into the potential mechanism underlying of pinealoblastoma pathology. Here, NSD1 is linked to Sotos syndrome.